Literature DB >> 15681705

Oxygen release from low and normal P50 Hb vesicles in transiently occluded arterioles of the hamster window model.

Hiromi Sakai1, Pedro Cabrales, Amy G Tsai, Eishun Tsuchida, Marcos Intaglietta.   

Abstract

A phospholipid vesicle encapsulating Hb [Hb vesicle (HbV)] has been developed as a transfusion alternative. One characteristic of HbV is that the O(2) affinity [Po(2) at which Hb is 50% saturated (P(50))] of Hb can be easily regulated by the amount of the coencapsulated allosteric effector pyridoxal 5'-phosphate. In this study, we prepared two HbVs with different P(50)s (8 and 29 mmHg, termed HbV(8) and HbV(29), respectively) and observed their O(2)-releasing behavior from an occluded arteriole in a hamster skinfold window model. Conscious hamsters received HbV(8) or HbV(29) at a dose rate of 7 ml/kg. In the microscopic view, an arteriole (diameter: 53.0 +/- 6.6 mum) was occluded transcutaneously by a glass pipette on a manipulator, and the reduction of the intra-arteriolar Po(2) 100 mum down from the occlusion was measured by the phosphorescence quenching of preinfused Pd-porphyrin. The baseline arteriolar Po(2) (50-52 mmHg) decreased to about 5 mmHg for all the groups. Occlusion after HbV(8) infusion showed a slightly slower rate of Po(2) reduction compared with that after HbV(29) infusion. The arteriolar O(2) content was calculated at each reducing Po(2) in combination with the O(2) equilibrium curves of HbVs, and it was clarified that HbV(8) showed a significantly slower rate of O(2) release compared with HbV(29) and was a primary source of O(2) (maximum fraction, 0.55) overwhelming red blood cells when the Po(2) was reduced (e.g., <10 mmHg) despite a small dosage of HbV. This result supports the possible utilization of Hb-based O(2) carriers with lower P(50) for oxygenation of ischemic tissues.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15681705     DOI: 10.1152/ajpheart.01184.2004

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  11 in total

1.  Simulation of NO and O2 transport facilitated by polymerized hemoglobin solutions in an arteriole that takes into account wall shear stress-induced NO production.

Authors:  Yipin Zhou; Pedro Cabrales; Andre F Palmer
Journal:  Biophys Chem       Date:  2012-01-09       Impact factor: 2.352

2.  Generation of functional erythrocytes from human embryonic stem cell-derived definitive hematopoiesis.

Authors:  Feng Ma; Yasuhiro Ebihara; Katsutsugu Umeda; Hiromi Sakai; Sachiyo Hanada; Hong Zhang; Yuji Zaike; Eishun Tsuchida; Tatsutoshi Nakahata; Hiromitsu Nakauchi; Kohichiro Tsuji
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-28       Impact factor: 11.205

3.  Simple method for preparing poly(ethylene glycol)-surface-conjugated liposome-encapsulated hemoglobins: physicochemical properties, long-term storage stability, and their reactions with O2, CO, and NO.

Authors:  Shahid Rameez; Andre F Palmer
Journal:  Langmuir       Date:  2011-06-16       Impact factor: 3.882

4.  Effect of oxygen affinity on systemic perfusion and brain tissue oxygen tension after extreme hemodilution with hemoglobin-starch conjugates in rats.

Authors:  Gregory M T Hare; Elaine Liu; Andrew J Baker; C David Mazer
Journal:  Intensive Care Med       Date:  2009-07-10       Impact factor: 17.440

5.  Hemoglobin conjugates with antioxidant enzymes (hemoglobin-superoxide dismutase-catalase) via poly(ethylene glycol) crosslinker for protection of pancreatic beta RINm5F cells in hypoxia.

Authors:  Venkatareddy Nadithe; You Han Bae
Journal:  Tissue Eng Part A       Date:  2011-07-11       Impact factor: 3.845

6.  Large scale production of vesicles by hollow fiber extrusion: a novel method for generating polymersome encapsulated hemoglobin dispersions.

Authors:  Shahid Rameez; Ibrahim Bamba; Andre F Palmer
Journal:  Langmuir       Date:  2010-04-06       Impact factor: 3.882

7.  Production of erythriod cells from human embryonic stem cells by fetal liver cell extract treatment.

Authors:  Yu-xiao Liu; Wen Yue; Lei Ji; Xue Nan; Xue-tao Pei
Journal:  BMC Dev Biol       Date:  2010-08-10       Impact factor: 1.978

8.  A computational model of oxygen delivery by hemoglobin-based oxygen carriers in three-dimensional microvascular networks.

Authors:  Nikolaos M Tsoukias; Daniel Goldman; Arjun Vadapalli; Roland N Pittman; Aleksander S Popel
Journal:  J Theor Biol       Date:  2007-06-16       Impact factor: 2.691

9.  Hemodilution with liposome-encapsulated low-oxygen-affinity hemoglobin does not attenuate hypothermic cerebral ischemia in rats.

Authors:  Teiji Oda; Tetsuhiro Kimura; Yoshitaka Ogata; Yutaka Fujise
Journal:  J Artif Organs       Date:  2005       Impact factor: 1.385

10.  Establishment of immortalized human erythroid progenitor cell lines able to produce enucleated red blood cells.

Authors:  Ryo Kurita; Noriko Suda; Kazuhiro Sudo; Kenichi Miharada; Takashi Hiroyama; Hiroyuki Miyoshi; Kenzaburo Tani; Yukio Nakamura
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.